Healius (HLS.AX) Osake Kurssi
Healius Kurssi
Viimeisten 19 vuoden aikana Healiusn liikevaihto kasvoi 8,9 % vuodessa ja ylsi 1,37 Mrd. AUD:een. Osakekohtainen tulos on kasvanut 6,9 % vuodessa viimeisten 15 vuoden aikana. Healiusn nettomarginaali −30,3 % on laskenut verrattuna 13,5 %:iin muutama vuosi sitten. Nykyhinnalla osinkotuotto on noin 1,57 %. Healiusn 12 kuukauden konsensustavoitehinta on 0,77 AUD, noin yli kurssia 104,0 %. 15 analyytikosta 1 suosittaa ostoa — kokonaiskonsensus on Myy.
Healius osakekurssi
Hae nämä tiedot Eulerpool API:n kautta
100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia
Healius liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Healius -osakkeesta
Healius Ltd is a leading healthcare company based in Australia. The company's business model revolves around delivering exceptional healthcare services and solutions. Healius operates a diverse range of medical centers, pathology laboratories, and imaging clinics throughout the country. With a focus on patient care and innovation, Healius aims to provide accessible and high-quality healthcare to individuals and communities. The company's comprehensive range of services includes general practitioner consultations, pathology testing, radiology imaging, and specialty healthcare options. Healius' business model centers on delivering efficient, integrated, and patient-centric healthcare solutions, making it a prominent player in the Australian healthcare industry.
Healius Ltd is primarily active in the healthcare industry.
The main competitors of Healius Ltd in the market include companies such as Sonic Healthcare, Primary Health Care, and Ramsay Health Care.
Healius Ltd, formerly known as Primary Health Care Ltd, is a leading Australian healthcare company. Established in 1985, Healius has a rich history of providing quality healthcare services to patients nationwide. Over the years, the company has evolved and expanded its offerings, including medical centers, pathology services, and diagnostic imaging. With a network of over 2,000 doctors and healthcare professionals, Healius focuses on delivering patient-centric care and innovative solutions. The company's commitment to excellence has made it a trusted name in the healthcare industry, providing comprehensive and accessible medical services to individuals and communities across Australia.
Healius Ltd has achieved significant milestones over the years. Some notable achievements include expanding its network of medical centers, introducing innovative healthcare services, and forging strategic partnerships. The company has also demonstrated consistent financial growth, delivering strong revenue and earnings results. Furthermore, Healius Ltd has focused on enhancing patient experiences and improving healthcare outcomes through technological advancements and process improvements. With its commitment to excellence, Healius Ltd continues to make strides in the healthcare industry, solidifying its position as a leading provider of integrated healthcare services.
Healius Ltd is primarily present in Australia.
Healius Ltd represents values of integrity, excellence, collaboration, and compassion. The company is committed to delivering high-quality healthcare services to its patients, fostering a culture of trust and accountability. With a focus on innovation and patient-centered care, Healius aims to provide accessible and efficient healthcare solutions. As a leading healthcare company in Australia, Healius embraces a corporate philosophy centered around continuously improving patient outcomes, investing in advanced technologies, and maintaining strong ethical standards. With its dedicated and skilled team, Healius is devoted to making a positive difference in people's lives through its diversified range of services and commitment to quality healthcare delivery.
Analyytikot asettavat tällä hetkellä Healius-osakkeelle keskimääräisen tavoitehinnan 0,75 AUD (mediaani: 0,77 AUD), mikä merkitsee +100,4 % viimeisimpään hintaan verrattuna. Konsensus perustuu 15 analyytikkoarvioon.
15 analyytikkoa arvioi tällä hetkellä Healius-osaketta: 0 suosittaa ostoa, 7 pitoa ja 8 myyntiä.
Nykyisellä valuuttakurssilla Healius-osake noteerataan hintaan 0,23 EUR (0,38 AUD).
Healius-osake (HLS.AX) on listattuna 4 pörssissä, muun muassa: SIX (Zürich) (PGZ.SW), ASX (HLS.AX), Frankfurt (PGZ.F), Düsseldorf (PGZ.DU).
Healius Ltd is an Australian company that offers a comprehensive portfolio of healthcare services. It is a leading provider of integrated medical services, focusing on medical imaging, pathology, radiology, telemedicine, and general medicine. The company was founded in 2018 and is headquartered in Sydney, Australia. The following describes Healius Ltd's business model in more detail, as well as the various divisions and products the company offers. Business model: Healius Ltd specializes in integrated medical services. The company offers a wide range of products and services at medical locations in Australia to ensure optimal customer satisfaction. The advantage of this business model is that it provides a broad customer base and the opportunity to offer various services to generate revenue. Divisions: Healius Ltd offers a range of specialties including medical imaging, pathology, radiology, telemedicine, and general medicine. It is a leading provider of integrated medical services in Australia. The company performs medical diagnostic tests and provides consulting services to ensure quick diagnosis and proper treatment for its customers. Products: Medical imaging and radiology are the core competencies of Healius Ltd. The company has state-of-the-art technology for performing X-rays, CT scans, MRIs, ultrasound examinations, etc. Moreover, the company offers pathology services for disease diagnosis and medical tests to enable accurate medical diagnoses. Telemedicine is another important service provided by Healius Ltd. The company offers virtual doctor consultations, allowing customers to address their health issues from the comfort of their homes. The company also provides an online service for patients to access their medical history. In summary, Healius Ltd is a leading provider of medical services in Australia, offering a wide range of products and services to ensure optimal customer satisfaction. The company has a strong presence in various specialties such as medical imaging, pathology, radiology, telemedicine, and general medicine. The company has strong growth potential as it has a broad customer base and offers a comprehensive portfolio of services and products to generate revenue.
liikevaihto Healius on 1,37 Mrd. AUD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
voitto Healius on −415,60 M AUD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Healius:n hinta-voitto-suhde (P/E) on tällä hetkellä −0,66. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Healius-osakkeen arvostusta.
Healius:n hinta-myynti-suhde (P/S) on tällä hetkellä 0,20. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Healius-osakkeen arvostuskennuslukuna.
Healius:n Eulpool-laatuscore on 0/10.
Healius:n ISIN on AU0000033359. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Healius:n WKN on A2PAL9. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
Healius:n ticker on HLS.AX. Tämä pörssinoteeraus käytetään Healius-osakkeiden kauppaan pörssissä.
Healius osake
Healius vertaisryhmä
Healius Ticker
Healius FIGI
Kaikki tunnusluvut ja syvällinen analyysi Healius:sta
Meidän osakeanalyysimme Healius-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Healius:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: